Previous studies have shown that the tumor-related genes ADAMTS9 (ADAM metallopeptidase with thrombospondin type 1 motif 9) and MAPT are regulated by their corresponding antisense long non-coding RNAs, respectively, in glioma and ER-negative breast cancer [33, 34]. The gene discussed is MAPT; the disease is central nervous system cancer.